Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

121.91
Delayed Data
As of 4:00pm ET
 -0.13 / -0.11%
Today’s Change
97.52
Today|||52-Week Range
164.04
-22.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues914.1M1.1B1.3B1.5B
 
 
 
 
 
Cost of Goods Sold92.2M99.9M93.6M36.1M
 
 
 
 
 
Depreciation And Amortization27.1M31.3M32.2M32.9M
 
 
 
 
 
 
Operating ExpensesGross Income794.8M985.9M1.2B1.4B
 
 
 
 
 
General Expenses368.3M693.4M623.8M697.7M
 
 
 
 
 
Research And Development173.4M299.3M242.5M245.1M
 
 
 
 
 
Total Operating Expenses487.6M824.5M749.7M766.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income426.4M292.5M538.8M699.0M
 
 
 
 
 
Extraordinary Credit33.7M210.0K0.000.00
 
 
 
Extraordinary Charge-6.8M0.00-1.1M0.00
 
 
 
Pre-Tax Equity Earnings-143.0K----0.00
 
 
Interest Expense On Debt17.5M18.1M17.6M4.7M
 
 
 
 
 
Other Expenses203.0K425.0K5.1M350.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income440.7M278.9M525.2M1.0B
 
 
 
 
 
Income Taxes-136.2M-104.3M-185.1M-392.8M
 
 
 
 
 
Net Income304.4M174.6M340.1M651.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.1M50.1M48.2M46.0M
 
 
 
 
 
Shares To Calculate EPS Diluted53.3M53.2M54.2M51.2M
 
 
 
 
 
 
Earnings Per ShareEPS$5.71$3.28$6.28$12.72
 
 
 
 
 
EPS Diluted$5.71$3.28$6.28$12.72